Education
About Us
Working with TipRanks
Follow Us
ImmuneOnco Biopharmaceuticals (Shanghai) Inc Class H (HK:1541)
:1541
Comparison Results
ImmuneOnco Biopharmaceuticals (Shanghai) Inc Class H
HK$12.56
HK$11.60B
―
91.17%
0 Buy
0 Hold
0 Sell
Hold
Ascletis Pharma, Inc.
HK$9.52
HK$10.49B
―
605.19%
1 Buy
1 Hold
0 Sell
Moderate Buy
Lepu Biopharma Co. Ltd. Class H
HK$7.15
HK$13.44B
―
110.29%
0 Buy
0 Hold
0 Sell
Hold
Biocytogen Pharmaceuticals (Beijing) Co. Ltd. Class H
HK$25.08
HK$10.67B
70.94
236.19%
0 Buy
0 Hold
0 Sell
Hold
CStone Pharmaceuticals
HK$6.80
HK$11.92B
―
293.06%
0 Buy
0 Hold
0 Sell
Moderate Buy
Shandong Boan Biotechnology Company., Limited. Class H
HK$12.03
HK$7.65B
194.66
21.52%
―
Performance Comparison
HK:1541
ImmuneOnco Biopharmaceuticals (Shanghai) Inc Class H
12.56
6.55
108.99%
HK:1672
Ascletis Pharma, Inc.
9.52
8.22
632.31%
HK:2157
Lepu Biopharma Co. Ltd. Class H
7.15
4.07
132.14%
HK:2315
Biocytogen Pharmaceuticals (Beijing) Co. Ltd. Class H
25.08
17.92
250.28%
HK:2616
CStone Pharmaceuticals
6.80
5.08
295.35%
HK:6955
Shandong Boan Biotechnology Company., Limited. Class H
12.03
2.52
26.50%